Cost-Effectiveness of Trastuzumab Deruxtecan in Patients with Unresectable or Metastatic HER2-Low Breast Cancer Who Have Received Prior Chemotherapy
Titel:
Cost-Effectiveness of Trastuzumab Deruxtecan in Patients with Unresectable or Metastatic HER2-Low Breast Cancer Who Have Received Prior Chemotherapy
Auteur:
Paulissen, Jeroen Hendrikus Jacobus van Schoonhoven, Alexander Victor Olin, Emma Postma, Arjan Jacobus Mbanya, Zacharie Dunton, Kyle John Postma, Maarten Jacobus van Hulst, Marinus Freriks, Roel Donald